![]() |
市场调查报告书
商品编码
1702140
2025 年至 2033 年宠物糖尿病照护市场报告,按解决方案(治疗、血糖监测设备)、动物类型(狗、猫)、配销通路(兽医院和诊所、零售药局、网路商店)和地区划分Pet Diabetes Care Market Report by Solution (Treatment, Glucose Monitoring Devices), Animal Type (Dogs, Cats), Distribution Channel (Veterinary Hospitals and Clinics, Retail Pharmacies, Online Stores), and Region 2025-2033 |
2024 年全球宠物糖尿病照护市场规模达 22 亿美元。展望未来, IMARC Group预计到 2033 年市场规模将达到 39 亿美元,2025-2033 年期间的成长率 (CAGR) 为 6.43%。宠物肥胖症的日益普及、宠物人性化趋势的出现、主要参与者的广泛研发 (R&D) 活动以及消费者支出能力的提高是推动市场发展的一些主要因素。
宠物糖尿病护理是指兽医学的一个专业领域,涉及狗和猫的糖尿病的诊断、治疗和管理。它涉及对患有糖尿病的宠物进行全面的护理和支持,糖尿病是一种以身体无法正常调节血糖水平为特征的慢性疾病。宠物糖尿病照护涵盖多个方面,包括定期监测血糖水平、胰岛素注射、饮食管理和宠物的生活方式改变。接受过该领域培训的兽医和兽医专业人员与宠物主人密切合作,制定个人化的治疗计划,向他们讲解疾病知识,并提供持续的支持。宠物糖尿病照护的目标是透过医疗干预、饮食管理和生活方式改变相结合的方式优化宠物的生活质量,预防与糖尿病相关的健康併发症,并实现有效的血糖控制。
由于久坐的生活方式、肥胖、遗传倾向和宠物数量老化,宠物糖尿病盛行率上升将在预测期内刺激市场的成长。此外,宠物人性化的新兴趋势以及宠物主人为伴侣动物提供最佳医疗保健的日益增长的需求加速了宠物主人对产品的采用率。宠物主人愿意在定期兽医检查、糖尿病管理工具和特殊饮食上投入更多,以确保他们的宠物得到适当和及时的照顾。除此之外,兽医学和技术的众多进步,包括扩大宠物糖尿病治疗方案的范围(如改进的胰岛素配方、血糖监测设备以及促进远端监测和咨询的远距医疗解决方案),正在推动市场成长。此外,宠物主人和兽医专业人士对宠物糖尿病的认识和教育不断提高,也促进了市场的成长。
宠物肥胖率上升
宠物肥胖率的上升是推动宠物糖尿病照护解决方案需求的一个主要因素。随着越来越多的宠物变得超重或肥胖,它们患糖尿病的风险更高。宠物主人越来越意识到宠物肥胖带来的健康风险,包括糖尿病的可能性更高,因此正在寻求解决方案来解决和预防这些疾病。这反过来又导致了对体重管理计划、特殊饮食和运动方案的需求不断增长,旨在帮助宠物保持健康的体重并降低糖尿病和相关疾病的风险。除此之外,对抗宠物肥胖的关注度日益提高,也促进了与宠物糖尿病护理相关的新产品和服务的开发,旨在帮助宠物主人透过有效的体重管理策略来预防和管理糖尿病。
越来越关注宠物健康和保健
对宠物健康和保健的日益关注是市场的另一个主要驱动力。宠物主人投入大量资金来确保宠物的整体健康,并寻求预防性医疗保健解决方案和糖尿病等慢性病的综合管理。他们更积极主动地监测宠物的健康状况,定期进行兽医检查,并对潜在的健康问题更加警觉。宠物主人观念的重大转变加强了对专业宠物糖尿病照护的需求,包括定期监测血糖水平、胰岛素注射和饮食管理。市场正在透过提供创新产品和服务(如先进的血糖监测系统、胰岛素笔和专门的糖尿病宠物食品配方)来应对这一趋势。宠物主人也积极寻求有关管理宠物糖尿病的资讯和资源,从而提高了人们对该主题的认识和教育。
兽医学和技术的进步
兽医学和技术的不断进步显着改善了宠物糖尿病的管理,并推动了市场发生积极变化。这些进步包括开发更准确、更用户友善的血糖监测系统,使宠物主人能够方便、准确地监测宠物的血糖值。此外,远距医疗和远端监控工具的整合使得糖尿病管理更加便捷和高效,因为宠物主人可以获得兽医专业人员的指导和支持,而无需频繁亲自拜访。此外,电子健康记录和资料分析的日益使用改善了糖尿病宠物的整体管理和治疗效果。兽医学和技术的这些创新为宠物主人提供了更好的工具和资源来管理宠物的疾病,并提高了糖尿病宠物的整体护理和生活品质。
The global pet diabetes care market size reached USD 2.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.9 Billion by 2033, exhibiting a growth rate (CAGR) of 6.43% during 2025-2033. The increasing prevalence of obesity in pets, the emerging pet humanization trend, extensive research and development (R&D) activities by key players, and rising expenditure capacities of consumers are some of the major factors propelling the market.
Pet diabetes care refers to the specialized field of veterinary medicine that deals with the diagnosis, treatment, and management of diabetes in dogs and cats. It involves comprehensive care and support for pets with diabetes mellitus, a chronic condition characterized by the body's inability to properly regulate blood sugar levels. Pet diabetes care encompasses various aspects, including the regular monitoring of blood glucose levels, insulin administration, dietary management, and lifestyle modifications of pets. Veterinarians and veterinary professionals trained in this field work closely with pet owners to create individualized treatment plans, educate them about the disease, and provide ongoing support. The goal of pet diabetes care is to optimize the pet's quality of life, prevent health complications associated with diabetes, and achieve efficient glycemic control through a combination of medical intervention, dietary management, and lifestyle modifications.
The rising prevalence of diabetes in pets due to sedentary lifestyles, obesity, genetic predisposition, and an aging pet population will stimulate the growth of the market during the forecast period. Moreover, the emerging trend of pet humanization and the growing desire of pet owners to provide optimal healthcare for companion animals have accelerated the product adoption rate among pet owners. Pet owners are willing to invest more in regular veterinary visits, diabetes management tools, and specialized diets to ensure that their pets receive proper and timely care. Apart from this, numerous advancements in veterinary medicine and technology, including the expansion of the range of treatment options available for pet diabetes such as improved insulin formulations, glucose monitoring devices, and telemedicine solutions that facilitate remote monitoring and consultation is propelling the market growth. Furthermore, the heightening awareness and education about pet diabetes among owners and veterinary professionals is contributing to the market growth.
Increase in pet obesity rates
The rising prevalence of obesity among pets is a major factor driving the demand for pet diabetes care solutions. As more and more pets become overweight or obese, they are at a higher risk of developing diabetes. Pet owners are becoming increasingly aware of the health risks associated with obesity in their pets, including the higher likelihood of diabetes, and are therefore seeking solutions to address and prevent these conditions. This in turn has led to a growing demand for weight management programs, specialized diets, and exercise regimens designed to help pets maintain a healthy weight and reduce the risk of developing diabetes and associated conditions. Besides this, the increasing focus on combating pet obesity is encouraging the development of new products and services related to pet diabetes care, aimed at helping pet owners prevent and manage diabetes through effective weight management strategies.
Growing focus on pet health and wellness
The growing focus on pet health and wellness is another major driver in the market. Pet owners are heavily investing in ensuring the overall well-being of their pets and are seeking preventive healthcare solutions and comprehensive management of chronic conditions like diabetes. They have become more proactive in monitoring their pets' health, are going for regular veterinary check-ups and being more vigilant about potential health issues. This substantial shift in pet owners' mindset has strengthened the demand for specialized pet diabetes care, including regular monitoring of blood glucose levels, insulin administration, and dietary management. The market is responding to this trend by offering innovative products and services such as advanced glucose monitoring systems, insulin pens, and specialized diabetic pet food formulations. Pet owners are also actively seeking information and resources on managing diabetes in pets, leading to a surge in awareness and education on the topic.
Advancements in veterinary medicine and technology
Constant advancements in veterinary medicine and technology have significantly improved the management of diabetes in pets and are driving positive changes in the market. These advancements include the development of more accurate and user-friendly glucose monitoring systems, which enable pet owners to monitor their pets' blood sugar levels conveniently and accurately. Additionally, the integration of telemedicine and remote monitoring tools has enabled more convenient and efficient diabetes management, as pet owners can receive guidance and support from veterinary professionals without the need for frequent in-person visits. Furthermore, the increasing use of electronic health records and data analytics has improved the overall management and treatment outcomes of pets with diabetes. These innovations in veterinary medicine and technology are providing pet owners with better tools and resources for managing the disease in their pets, enhancing the overall care and quality of life for diabetic pets.
Treatment represents the most popular solution
Treatment plays a crucial role in driving the market growth as it encompasses a range of interventions and therapies aimed at managing diabetes in pets. Effective treatment options are essential to provide optimal care and improve the quality of life for pets with diabetes. Treatment fuels the market growth by creating a consistent and steady demand for various products and services, such as insulin formulations, glucose monitoring systems, specialized diabetic pet food, and veterinary consultations.
Furthermore, the easy availability of diverse treatment options allows pet owners and veterinary professionals to tailor the management approach to the individual needs of each pet, which in turn is propelling the market growth. Moreover, ongoing advancements in treatment options, including improved insulin formulations and delivery methods, advanced glucose monitoring technologies, and personalized nutrition, further contribute to the growth of the market.
Dogs dominate the market
Dogs play a significant role in propelling the market due to their high prevalence of diabetes and the growing awareness of this condition among dog owners. Dogs are more susceptible to developing diabetes compared to other pets, and as a result, there is a greater demand for specialized care and management options for diabetic dogs. The increasing prevalence of obesity in dogs, which is a major risk factor for diabetes, further contributes to the need for pet diabetes care solutions for dogs.
Furthermore, dog owners are becoming more educated about the symptoms, diagnosis, and treatment of diabetes in dogs, leading to more frequent veterinary visits and the adoption of appropriate disease management strategies. This growing awareness drives the development and availability of specific products and services tailored to diabetic dogs, including glucose monitoring devices, insulin formulations, diabetic dog food, and educational resources. The unique role of dogs in the market for pet diabetes care underscores the importance of addressing their specific needs and fueling advancements in diabetes management for this companion animal.
Veterinary hospitals and clinics hold the largest share in the market
Veterinary hospitals and clinics are the primary providers of specialized care and treatment for pets with diabetes. These healthcare facilities serve as the central hub for diagnosing, monitoring, and managing diabetes in pets. Veterinary hospitals and clinics offer crucial services such as blood glucose monitoring, insulin administration, dietary counseling, and regular check-ups to ensure effective diabetes management in pets. They play a vital role in educating pet owners about the importance of diabetes care, including the need for regular veterinary visits, adherence to treatment plans, and lifestyle modifications. Furthermore, these healthcare facilities often stock and dispense diabetes-related products such as insulin, glucose monitoring devices, and specialized diabetic pet food, contributing to the widespread availability and accessibility of these essential supplies. Veterinary hospitals and clinics are at the forefront of research and advancements in pet diabetes care, driving innovations and improving treatment options. Their expertise and guidance are crucial in improving the quality of life of pets with diabetes and fostering the growth of the market.
North America exhibits a clear dominance in the market
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for pet diabetes care.
North America held the biggest share in the market since the region has a high pet ownership rate and a strong culture of pet care, resulting in a large market for pet healthcare products and services, including diabetes care. The rising awareness and understanding of pet diabetes among pet owners in North America contributes to the high demand for specialized care and treatment options. Veterinary clinics and hospitals in the North America region are at the forefront of research, innovation, and advancements in pet diabetes management, fostering the development of new products and treatment protocols.
Additionally, North America has a well-established veterinary healthcare infrastructure with an extensive network of veterinary professionals and specialized pet care facilities, ensuring easy accessibility to pet diabetes care. The large presence of leading pharmaceutical and healthcare companies in the region further supports the growth of the market in North America through the development and distribution of diabetes management products, including insulin, glucose monitoring devices, and specialized pet food.
The market is experiencing a lower-than-anticipated demand compared to pre-pandemic levels. However, this is likely to witness a paradigm shift over the next decade with the development of advanced glucose monitoring systems specifically designed for pets. Moreover, there have been advancements in insulin formulations and delivery methods, offering improved options for insulin administration and absorption. Key players are also introducing long-acting insulin formulations that provide more stable blood glucose control and reduce the frequency of injections. Additionally, the leading manufacturers are integrating telemedicine and remote monitoring technologies, enabling pet owners to consult with veterinary professionals and receive guidance on diabetes management from the comfort of their homes. We also expect the market to witness new entrants, consolidation of product portfolios, increased research-related efforts by key players, and a rise in strategic collaborations to drive healthy competition within the domain.